Tianlong, together with its parent company KHB Group, successfully concluded its participation at WHX Labs Dubai 2026. The exhibition served as a key platform to showcase Tianlong’s latest advancements in molecular diagnostics and intelligent laboratory solutions to global partners and healthcare professionals.
As a leading laboratory medicine event in the Middle East, WHX Labs Dubai gathered IVD manufacturers, laboratories, research institutes, and industry decision-makers from around the world. During the exhibition, Tianlong welcomed visitors from the Middle East, Africa, Europe, and Asia, engaging in productive discussions through live demonstrations and technical exchanges on evolving diagnostic needs and future cooperation.
iGenebox 3A | Fully Automated Molecular POCT System
Making its first appearance at the exhibition, the iGenebox 3A Fully Automated Nucleic Acid Analyzer became one of the spotlight products at Tianlong’s booth.
Designed as a molecular testing POCT system, the iGenebox 3A delivers results within 20–25 minutes, enabling rapid testing in time-sensitive scenarios. With two independent modules and four fluorescence channels, it supports detection of up to 24 targets from a single sample, suitable for multiplex assays including influenza, Mycoplasma pneumoniae, monkeypox, and more. Notably, in response to the recent global concern surrounding Nipah virus outbreaks, Nipah virus detection has been rapidly incorporated into the system’s testing menu, further expanding its capability in emerging infectious disease surveillance.
Visitors showed strong interest in its compact design, operational convenience, and multi-application capability. Many noted that the system is small, flexible, easy to use, and delivers fast results, making it highly practical for decentralized and on-site molecular testing settings.
Biolum Plus | New-Generation Intelligent ATP Hygiene Monitoring System
Making its debut as a newly upgraded product at this year’s exhibition, Biolum Plus represents the intelligent evolution of the Biolum series. While retaining the proven 10-second rapid detection capability and stable performance of the standard model, Biolum Plus introduces an integrated Wi-Fi communication module, enabling the connection to the Tianlong Cloud Platform for real-time data upload, centralized storage, and visualized analysis across multiple testing sites.
From single-point detection to network-wide management, and from local data handling to cloud-based collaboration, Biolum Plus is not only an efficient testing device but also a comprehensive solution supporting healthcare institutions and enterprises in building digitalized and intelligent hygiene quality monitoring systems.
On site, professionals from infection control and food safety sectors spoke highly of its cloud data management capabilities, noting that it provides a practical and innovative approach for unified hygiene supervision across multi-facility environments.
Panall 8000 | All-in-One Molecular Diagnosis System
The Panall 8000 continued to draw strong attention for its fully integrated “sample-in, result-out” workflow design.
Combining nucleic acid extraction, amplification, and detection into a single platform, the system streamlines laboratory operations while reducing manual handling steps. Its open compatibility with third-party PCR reagents provides laboratories with enhanced flexibility in assay menu expansion and localized test development.
Visitors particularly valued its efficiency advantages for small- to medium-sized laboratories, clinics, and hospitals seeking automation without complex infrastructure requirements.
MF200 | Multifunctional Veterinary Analyzer
The FOCUS PEGASUS MF200 multifunctional veterinary analyzer remained a key attraction among animal health professionals.
Integrating biochemistry, electrolytes, coagulation, and immunofluorescence testing into a single platform, the MF200 delivers rapid, comprehensive diagnostic results for veterinary applications. Its streamlined workflow and multi-parameter capability support improved efficiency in veterinary clinics and animal health laboratories.
Blood Safety & Precision Medicine | Integrated NAT Solutions
From large-scale blood screening to individualized treatment monitoring, Tianlong, in partnership with KHB, delivers end-to-end nucleic acid testing (NAT) solutions spanning both blood supply safety and clinical efficacy assessment.
For blood screening, the multiplex assays enable simultaneous detection of HBV, HCV, and HIV (Type 1 & 2) in a single reaction, providing high analytical sensitivity and effectively shortening the infectious diagnostic window period. Compatible with automated platforms including the Panall 8000 and Aurora PANA X6, the solution supports both individual donation and 6-in-1 pooled testing workflows, achieving throughput of up to 576 samples per batch. It is trusted by more than 100 blood centers and hospitals nationwide, supporting annual testing volumes exceeding ten million samples with sustained 100% performance in external quality assessment (EQA) programs.
In clinical applications, KHB’s quantitative assays for HBV, HCV, and HIV-1 are built on internal standard method, enabling full-process quality monitoring from nucleic acid extraction through amplification within each reaction. This design ensures accurate viral load quantification, effectively mitigates inhibition interference, and safeguards result reliability—providing robust evidence for treatment response evaluation and personalized antiviral therapy management.
Aurora PANA X6 | Automated Nucleic Acid Extraction System
The Aurora PANA X6 is a fully automated, all-in-one nucleic acid extraction platform engineered for high-throughput blood screening workflows.
Its integrated modular design consolidates sample loading, capping/decapping, pooling, extraction, and PCR setup into a unified process. When paired with the Gentier 96 Real-time PCR System, it enables a true sample-in, result-out workflow with minimal hands-on time.
The system supports up to 576 samples per run and 1,152 samples per day, with automated 6-in-1 pooled testing performed directly into deep-well plates. Dual extraction and PCR modules ensure parallel processing efficiency.
To maintain testing integrity, the platform incorporates multiple contamination control—including physical zoning, directional airflow, UV disinfection, HEPA filtration, and anti-drop design—alongside high-precision liquid handling and intelligent barcode identification.
Strengthening Global Collaboration
Across the exhibition, Tianlong held extensive discussions with distributors, laboratory representatives, and industry partners from multiple regions. Engagements focused on product localization, regulatory registration pathways, and long-term distribution cooperation.
These interactions not only strengthened existing partnerships but also opened new channels for market expansion across the Middle East, Africa, and emerging international markets.
Looking Ahead
WHX Labs Dubai 2026 was another important stop in Tianlong’s global exhibition calendar. By showcasing integrated diagnostic platforms and launching innovative molecular POCT solutions, Tianlong reinforced its commitment to advancing accessible and efficient healthcare technologies worldwide.
We extend our sincere appreciation to all visitors and partners who joined us in Dubai. Tianlong will continue to drive innovation, deepen global collaboration, and deliver high-quality diagnostic solutions that contribute to a healthier future.
